.
.
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
"we know that hdl, the good cholesterol, is low in psoriasis, but here, we now show that despite reduction in systemic
.
.